And the vasculature.

This content was reprinted from kaiserhealthnews.org with permission from the Henry J. Kaiser Family members Foundation. Kaiser Health Information, an editorially independent information service, is an application of the Kaiser Family Foundation, a nonpartisan health care policy research firm unaffiliated with Kaiser Permanente.. Acceleron Pharma announces study outcomes of its ACE-536 and ACE-011 bloodstream forming agents Acceleron Pharma, Inc., a biopharmaceutical business developing novel therapeutics that modulate the growth of tissues and cells including reddish blood cells, bone, muscle, extra fat, and the vasculature, announced that results from preclinical and scientific studies of two today, novel blood forming agents, ACE-536 and ACE-011, will be presented at the 51st Annual Interacting with of the American Culture of Hematology at the Ernest N.The ASHP Practitioner Recognition Program rewards excellence in pharmacy practice by granting acknowledgement through the FASHP designation. Members who’ve achieved FASHP status have successfully demonstrated sustained dedication or contributions to excellence in practice for at least 10 years, contributed to the full total body of understanding in the field, demonstrated energetic involvement and leadership in ASHP, and also have been actively involved with and committed to educating practitioners and others. The program has recognized 838 Fellows because it began in 1988. The 2015 Fellows are: Glen E. Albracht, Pharm.D., M.S., W. G. Hefner Veterans Affairs INFIRMARY, Salisbury, NC Emily Alexander, Pharm.D., BCPS, Envision Telepharmacy, Alpine, TX Brian D.